Jaume Aguado

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Emergency Department

Chronic Obstructive Pulmonary Disease

Acute Myocardial Infarction

Cross Sectional

Top Venues

Clinical drug investigation

Scientific reports

American journal of epidemiology

International journal of chronic obstructive pulmonary disease

This page only lists publications with an associated author ORCID identifier.

Publications

Jaume Aguado, Lia Gutiérrez, Joan Forns, Julia Vila-Guilera, Kenneth J Rothman, Xabier Garcia de Albeniz
Effect of Different Durations of Treatment With Antihypertensive Drugs With Anticholinergic Effects on the Risk of Dementia: A Target Trial Emulation Study. American journal of epidemiology (2024)
Cristina Rebordosa, Estel Plana, Annalisa Rubino, Jaume Aguado, David Martinez, Alejhandra Lei, Sami Daoud, Nuria Saigi-Morgui, Susanna Perez-Gutthann, Elena Rivero-Ferrer
Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists. International journal of chronic obstructive pulmonary disease 17 (2022)
Elena Rivero-Ferrer, Morten Olesen, Estel Plana, Jaume Aguado, Nuria Saigi-Morgui, Annalisa Rubino, Sami Z Daoud, Alejhandra Lei, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Jesper Hallas, Cristina Rebordosa, Cristina Rebordosa
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. Clinical drug investigation 42 (4) (2022)
Cristina Rebordosa, Dóra Körmendiné Farkas, Jukka Montonen, Kristina Laugesen, Florian Voss, Jaume Aguado, Ulrich Bothner, Kenneth J Rothman, Kristina Zint, Daniel Mines, Vera Ehrenstein
Cardiovascular events and all-cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long-acting beta2-agonists. Pharmacoepidemiology and drug safety 31 (8) (2022)
Cristina Rebordosa, Eline Houben, Kristina Laugesen, Ulrich Bothner, Jukka Montonen, Jaume Aguado, Jetty A Overbeek, Vera Ehrenstein, Joelle Asmar, Laura Wallace, Alicia W Gilsenan
No Evidence of Off-label Use of Olodaterol and Indacaterol in Denmark, France, and the Netherlands: A Drug Utilization Study. Scientific reports 10 (1) (2020)